← Back to All Filings

Globus Medical Director Files Intent to Sell $2.15M in Stock

Low SignificanceNovember 12, 2025 at 1:04:33 PM EST

GLOBUS MEDICAL INC

$GMED144CIK: 0001237831

Subscribe to track GMED

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Globus Medical Director Files Intent to Sell $2.15M in Stock

Company: GLOBUS MEDICAL INC (GMED) Form: 144 | Filed: 2025-11-12 Significance: Low

Insider: Davidar David D Title: Director | Relationship: Director

Transaction: • Type: Proposed Sale (via Cashless Option Exercise) • Shares: 25,000 • Price: $85.95 • Value: $2,148,750 • Owned After: Not Disclosed

Key Insight: A director has filed a notice of a proposed sale of shares valued at approximately $2.15 million. The transaction size is very small relative to the company's market capitalization, representing less than 0.02% of the market cap and shares outstanding.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: GLOBUS MEDICAL INC (GMED)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director at Globus Medical has filed a notice of intent to sell 25,000 shares, valued at approximately $2.15 million, which were acquired through a cashless option exercise.
  • Market Impact: The transaction is considered immaterial and is unlikely to have a noticeable impact on the stock, given its small size relative to the company's large market capitalization.

Company Information

FieldValue
CompanyGLOBUS MEDICAL INC
Ticker SymbolGMED
CIK0001237831
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameDavidar David D
CIK0001555268
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-12
Transaction CodeS (Proposed Sale)
Security TypeCommon Stock
Shares Involved25,000
Price Per Share$85.95
Total Value$2,148,750
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$2,148,750
% of Market Cap0.019%
Shares Transacted25,000
% of Shares Outstanding0.019%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $2.15 million sale is negligible for a company with an $11.56 billion market capitalization. Such transactions are routine and do not signal a significant change in insider sentiment.
  • Transaction Significance: Based on the transaction constituting less than 0.02% of both market cap and shares outstanding, its significance is low. It does not meet the thresholds for moderate or high significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale is too small to be considered a material event for a large-cap company like Globus Medical. It is likely part of a planned financial strategy by the director and does not imply a negative outlook on the company's future.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The transaction size is unlikely to cause any unusual trading volume.
  • Sentiment Indicator: Neutral. The market will likely view this as a routine, non-eventful insider transaction.

Additional Context

Transaction Notes

  • The filing is a Form 144, which is a notice of proposed sale of securities. The sale is related to a cashless option exercise, a common method for insiders to realize value from their equity compensation.
Topics:#SECFiling#InsiderTrading#Form144#GMED#GlobusMedical#InsiderSell#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.